Comparison of Vasopressin and Other Pressors in Septic Shock
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the classical tactics in the treatment of septic
shock (dopamine, noradrenalin and dobutamine) to the use of vasopressin as first choice
pressor.
Vasopressin seems to be an interesting alternative in the treatment of septic shock. To this
date, available studies have showed that it could correct hyperkinetic syndrome and
vasoplegia in septic shocks without noticeable side effect. It as been demonstrated that
vasopressin improves renal function, as no effect on digestive organs and as no metabolic
effect.